Last Updated: August 9, 2026

CYCRIN Drug Patent Profile

Name: CYCRIN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Cycrin, and what generic alternatives are available?

Cycrin is a drug marketed by Esi and is included in three NDAs.

The generic ingredient in CYCRIN is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cycrin

A generic version of CYCRIN was approved as medroxyprogesterone acetate by BARR on August 9^th, 1996.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CYCRIN?
What are the global sales for CYCRIN?
What is Average Wholesale Price for CYCRIN?

Summary for CYCRIN

US Patents:	0
Applicants:	1
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	73
Clinical Trials:	3
Patent Applications:	4,249
DailyMed Link:	CYCRIN at DailyMed

Drug patent expirations by year for CYCRIN

Recent Clinical Trials for CYCRIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Cancer Institute (NCI)	Early Phase 1
NRG Oncology	Early Phase 1
Women's Health Care Clinic, Torrance, California	Phase 4

See all CYCRIN clinical trials

US Patents and Regulatory Information for CYCRIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Esi	CYCRIN	medroxyprogesterone acetate	TABLET;ORAL	081239-001	Oct 30, 1992		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Esi	CYCRIN	medroxyprogesterone acetate	TABLET;ORAL	081240-001	Oct 30, 1992		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Esi	CYCRIN	medroxyprogesterone acetate	TABLET;ORAL	089386-001	Sep 9, 1987		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.